How many clinical trials are studying Ketamine Hydrochloride?

12 recruiting trials in our tracked data involve Ketamine Hydrochloride.

What conditions is Ketamine Hydrochloride being studied for?

In our tracked recruiting trials, Ketamine Hydrochloride is being studied in trials for Depression, Major Depressive Disorder, Treatment Resistant Depression.

Ketamine Hydrochloride: clinical trials recruiting now

Q: Is Ketamine Hydrochloride FDA-approved?

Yes. According to the FDA drug label available through openFDA, Ketamine Hydrochloride is an FDA-approved drug.

Recruiting trials

Conditions studied

US states with sites

Countries

FDA drug label

FDA-approved: Yes. Ketamine Hydrochloride appears in the FDA drug-label database. Marketed as Ketalar.

FDA-approved use

KETALAR (ketamine hydrochloride) injection is indicated: as the sole anesthetic agent for diagnostic and surgical procedures that do not require skeletal muscle relaxation. for the induction of anesthesia prior to the administration of other general anesthetic agents. as a supplement to other anesthetic agents. KETALAR is a general anesthetic indicated: as the sole anesthetic agent for diagnostic and surgical procedures that do not require skeletal muscle relaxation ( 1 ) for the induction of anesthesia prior to the administration of other general anesthetic agents ( 1 ) as a supplement to other anesthetic agents ( 1 ).

FDA label via openFDA

Phase breakdown

Phase 1 1 Phase 2 8 Phase 3 5

Conditions being studied

Condition	Trials
Depression · Ketamine Hydrochloride for Depression	10
Major Depressive Disorder · Ketamine Hydrochloride for Major Depressive Disorder	5
Treatment Resistant Depression · Ketamine Hydrochloride for Treatment Resistant Depression	3
Bipolar disorder	2
Major Depressive Disorder (MDD)	2
Suicidal Ideation	2
Alcohol Use Disorder	1
Bipolar Depression	1
Bipolar Disorder (BD)	1
Bipolar Disorder I or II	1
Borderline Personality Disorder (BPD)	1
Chronic Low Back Pain	1
Drug Resistant Epilepsy	1
Epilepsy	1
Healthy Volunteers	1

Recruiting trials involving Ketamine Hydrochloride

Imaging Depression in Parkinson's Disease
NCT06402955 · Phase: Phase 2 · Ages: 40 Years to 80 Years · Sex: All (male and female) · 1 location
Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure
NCT05603104 · Phase: Phase 3 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
Ketamine Augmentation of ECT in Treatment-Resistant Depression
NCT07088380 · Phase: Phase 3 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
Ketamine With Dialectical Behavioural Therapy (DBT) for Suicidality in Individuals With Treatment-Resistant Depression and Borderline Personality Disorder (KET-DBT)
NCT07569198 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
Ketamine for Combined Depression and Alcohol Use Disorder
NCT06090422 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
Ketamine-assisted Integrative Treatment for Veterans With Chronic Low Back Pain and Comorbid Depression
NCT06419439 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
Neurobiology of Suicide
NCT02543983 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
Oral Ketamine for Treatment of Vaso-Occlusive Pain
NCT05378555 · Phase: Phase 3 · Ages: 12 Years to 24 Years · Sex: All (male and female) · 1 location
The Effect of a Six Week Intensified Pharmacological Treatment for Major Depressive Disorder Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.
NCT05973851 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 12 locations
The Efficacy of a Subanesthetic Doses of IV Ketamine in the Treatment Drug Resistant Epilepsy
NCT05019885 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
Understanding and Treating Suicidal Ideation With Ketamine
NCT06891300 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
i-CBT and IV Ketamine for Suicidality in Treatment-Resistant Depression: A Randomized, Midazolam-Controlled Clinical Trial
NCT06480500 · Phase: Phase 2 · Ages: 21 Years to 65 Years · Sex: All (male and female) · 1 location

Common questions

Is Ketamine Hydrochloride FDA-approved?

Yes, marketed as Ketalar.

How many recruiting trials involve Ketamine Hydrochloride?

12 recruiting trials across 15 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.